Successful control of a neonatal outbreak caused mainly by ST20 multidrug-resistant SHV-5-producing Klebsiella pneumoniae, Greece

BMC Pediatr. 2014 Apr 17:14:105. doi: 10.1186/1471-2431-14-105.

Abstract

Background: Extended spectrum beta-lactamase-producing Klebsiella pneumoniae (ESBL-Kp) infection can cause significant morbidity and mortality in neonates. We investigated a nosocomial ESBL-Kp outbreak in a neonatal intensive care unit (NICU) of the University Hospital of Larissa (UHL), Central Greece.

Methods: A total of sixty-four ESBL-Kp were studied; twenty six isolates were recovered from the NICU and were compared with thirty-eight randomly selected isolates from different wards of the hospital during the period March- December 2012. All isolates were characterized by antimicrobial susceptibility testing, ESBL-production by double-disk synergy test, molecular typing using BOX-PCR, whereas selected isolates were further characterized by beta lactamase and virulence gene content, multilocus sequence typing and phylogenetic analysis. All neonates affected by ESBL-Kp were put under strict contact isolation, along with appropriate infection control measures.

Results: The outbreak strain of ST20 multidrug-resistant SHV-5-producing K. pneumoniae was identified in all infected (n = 13) and three colonized neonates. A novel ST (ST1114) was also identified among SHV-5 producers (n = 10) recovered from nine colonized infants, but it was not related with ST20. Both STs were identified only in the NICU and not in other wards of the hospital. No ESBL-Kp were isolated from the hands of the nursing staff and the environment. Although we were not able to identify the source of the outbreak, no ESBL-Kp were isolated in the NICU after this period and we assumed that the outbreak was successfully controlled. All neonates received parenteral nutrition and most of them were delivered by caesarean section and showed low gestational age (<32 weeks) and low birth weights (<1500 g).

Conclusion: According to our knowledge, this is the first description of an outbreak of multidrug-resistant SHV-5 producing K. pneumoniae assigned to ST20.

MeSH terms

  • Catheterization, Central Venous
  • Cesarean Section
  • Chest Tubes
  • Cross Infection / drug therapy
  • Cross Infection / epidemiology
  • Cross Infection / microbiology*
  • DNA, Bacterial / isolation & purification
  • Disease Outbreaks
  • Drug Resistance, Multiple, Bacterial
  • Female
  • Gestational Age
  • Greece / epidemiology
  • Humans
  • Infant, Low Birth Weight
  • Infant, Newborn
  • Infection Control
  • Intensive Care Units, Neonatal*
  • Intubation
  • Klebsiella Infections / epidemiology*
  • Klebsiella pneumoniae / enzymology
  • Klebsiella pneumoniae / isolation & purification*
  • Male
  • Parenteral Nutrition
  • Risk Factors
  • beta-Lactamases / genetics
  • beta-Lactamases / isolation & purification*

Substances

  • DNA, Bacterial
  • beta-lactamase SHV-5
  • beta-Lactamases